• 1.

    American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®): American Psychiatric Pub; 2013.

  • 2.

    Lord C, Bishop SL. Recent advances in autism research as reflected in DSM-5 criteria for autism spectrum disorder. Annu Rev Clin Psychol. 2015;11:53–70. https://doi.org/10.1146/annurev-clinpsy-032814-112745.

    Article 
    PubMed 

    Google Scholar
     

  • 3.

    Constantino JN, Charman T. Diagnosis of autism spectrum disorder: reconciling the syndrome, its diverse origins, and variation in expression. Lancet Neurol. 2016;15(3):279–91. https://doi.org/10.1016/S1474-4422(15)00151-9.

    Article 
    PubMed 

    Google Scholar
     

  • 4.

    Grzadzinski R, Huerta M, Lord C. DSM-5 and autism spectrum disorders (ASDs): an opportunity for identifying ASD subtypes. Mol Autism. 2013;4:12. https://doi.org/10.1186/s13229-016-0072-1.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 5.

    Christensen DL, Braun KVN, Baio J, Bilder D, Charles J, Constantino JN, et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years – autism and developmental disabilities monitoring network, 11 sites, United States, 2012. MMWR Surveill Summ. 2018;65(13):1–23. https://doi.org/10.15585/mmwr.ss6513a1.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 6.

    Brignell A, Morgan AT, Woolfenden S, Klopper F, May T, Sarkozy V, et al. A systematic review and meta-analysis of the prognosis of language outcomes for individuals with autism spectrum disorder. Autism Dev Lang Impair. 2018;3:1–19. https://doi.org/10.1177/2396941518767610.

    Article 

    Google Scholar
     

  • 7.

    Salazar F, Baird G, Chandler S, Tseng E, O’sullivan T, Howlin P, et al. Co-occurring psychiatric disorders in preschool and elementary school-aged children with autism spectrum disorder. J Autism Dev Disord. 2015;45(8):2283–94. https://doi.org/10.1007/s10803-015-2361-5.

    Article 
    PubMed 

    Google Scholar
     

  • 8.

    Geschwind DH, State MW. Gene hunting in autism spectrum disorder: on the path to precision medicine. Lancet Neurol. 2015;14(11):1109–20. https://doi.org/10.1016/S1474-4422(15)00044-7.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 9.

    Myers SM, Challman TD, Bernier R, Bourgeron T, Chung WK, Constantino JN, et al. Insufficient evidence for “autism-specific” genes. Am J Hum Genet. 2020;106(5):587–95. https://doi.org/10.1016/j.ajhg.2020.04.004.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 10.

    Yuen RK, Szatmari P, Vorstman JA. The genetics of autism spectrum disorders. Autism and the pervasive developmental disorders: Cambridge, United Kingdom: Cambridge University Press; 2019. p. 112–28.

  • 11.

    Constantino JN. Deconstructing autism: from unitary syndrome to contributory developmental endophenotypes. Int Rev Psychiatry. 2018;30(1):18–24. https://doi.org/10.1080/09540261.2018.1433133.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 12.

    Patel J, Lukkes JL, Shekhar A. Overview of genetic models of autism spectrum disorders. Progress in brain research. 241: Elsevier; 2018. p. 1–36.

  • 13.

    Molosh AI, Shekhar A. Neurofibromatosis type 1 as a model system to study molecular mechanisms of autism spectrum disorder symptoms. Progress in brain research. 241: Elsevier; 2018. p. 37–62.

  • 14.

    Garg S, Green J. Studying child development in genetic models of ASD. Progress in brain research. 241: Elsevier; 2018. p. 159–92.

  • 15.

    Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 2010;152A(2):327–32. https://doi.org/10.1002/ajmg.a.33139.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 16.

    Korf BR, Wayne H, Patterson MC, TePas E. Neurofibromatosis type 1 (NF1): pathogenesis, clinical features, and diagnosis. UpToDate, Waltham, MA.: UpToDate Retrieved from www.uptodate.com; 2015.

  • 17.

    Pinto D, Delaby E, Merico D, Barbosa M, Merikangas A, Klei L, et al. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am J Hum Genet. 2014;94(5):677–94. https://doi.org/10.1016/j.ajhg.2014.03.018.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 18.

    Sato A. mTOR, a potential target to treat autism spectrum disorder. CNS Neurol Disord Drug Targets. 2016;15(5):533–43. https://doi.org/10.2174/1871527315666160413120638.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 19.

    Eissa N, Al-Houqani M, Sadeq A, Ojha SK, Sasse A, Sadek B. Current enlightenment about etiology and pharmacological treatment of autism spectrum disorder. Front Neurosci. 2018;12:304. https://doi.org/10.3389/fnins.2018.00304.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 20.

    Loth E, Murphy DG, Spooren W. Defining precision medicine approaches to autism spectrum disorders: concepts and challenges. Front Psychiatry. 2016;7:188. https://doi.org/10.2174/1871527315666160413120638.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 21.

    Morris SM, Acosta MT, Garg S, Green J, Huson S, Legius E, et al. Disease burden and symptom structure of autism in neurofibromatosis type 1: a study of the International NF1-ASD Consortium Team (INFACT). JAMA Psychiat. 2016;73(12):1276–84. https://doi.org/10.1001/jamapsychiatry.2016.2600.

    Article 

    Google Scholar
     

  • 22.

    Adviento B, Corbin IL, Widjaja F, Desachy G, Enrique N, Rosser T, et al. Autism traits in the RASopathies. J Med Genet. 2014;51(1):10–20. https://doi.org/10.1136/jmedgenet-2013-101951.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 23.

    Plasschaert E, Descheemaeker MJ, Van Eylen L, Noens I, Steyaert J, Legius E. Prevalence of autism spectrum disorder symptoms in children with neurofibromatosis type 1. Am J Med Genet B. 2015;168(1):72–80. https://doi.org/10.1002/ajmg.b.32280.

    CAS 
    Article 

    Google Scholar
     

  • 24.

    Walsh KS, Velez JI, Kardel PG, Imas DM, Muenke M, Packer RJ, et al. Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1. Dev Med Child Neurol. 2013;55(2):131–8. https://doi.org/10.1111/dmcn.12038.

    Article 
    PubMed 

    Google Scholar
     

  • 25.

    Garg S, Lehtonen A, Huson SM, Emsley R, Trump D, Evans DG, et al. Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study. Dev Med Child Neurol. 2013;55(2):139–45. https://doi.org/10.1111/dmcn.12043.

    Article 
    PubMed 

    Google Scholar
     

  • 26.

    Payne JM, Walsh KS, Pride NA, Haebich KM, Maier A, Chisholm A, et al. Social skills and autism spectrum disorder symptoms in children with neurofibromatosis type 1: evidence for clinical trial outcomes. Dev Med Child Neurol. 2020;62(7):813–9. https://doi.org/10.1111/dmcn.14517.

    Article 
    PubMed 

    Google Scholar
     

  • 27.

    Chisholm AK, Anderson VA, Pride NA, Malarbi S, North KN, Payne JM. Social function and autism spectrum disorder in children and adults with neurofibromatosis type 1: a systematic review and meta-analysis. Neuropsychol Rev. 2018;28(3):317–40. https://doi.org/10.1007/s11065-018-9380-x.

    Article 
    PubMed 

    Google Scholar
     

  • 28.

    Eijk S, Mous SE, Dieleman GC, Dierckx B, Rietman AB, de Nijs PFA, et al. Autism spectrum disorder in an unselected cohort of children with neurofibromatosis type 1 (NF1). J Autism Dev Disord. 2018;48(7):2278–85. https://doi.org/10.1007/s10803-018-3478-0.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 29.

    Garg S, Green J, Leadbitter K, Emsley R, Lehtonen A, Evans DG, et al. Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics. 2013;132(6):e1642–8. https://doi.org/10.1542/peds.2013-1868.

    Article 
    PubMed 

    Google Scholar
     

  • 30.

    Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet. 2014;383(9920):896–910. https://doi.org/10.1016/S0140-6736(13)61539-1.

    Article 
    PubMed 

    Google Scholar
     

  • 31.

    May T, Brignell A, Williams K. Autism spectrum disorder prevalence in children aged 12–13 years from the Longitudinal Study of Australian Children. Autism Res. 2020;13(5):821–7. https://doi.org/10.1002/aur.2286.

    Article 
    PubMed 

    Google Scholar
     

  • 32.

    Falkmer T, Anderson K, Falkmer M, Horlin C. Diagnostic procedures in autism spectrum disorders: a systematic literature review. Eur Child Adolesc Psychiatry. 2013;22(6):329–40. https://doi.org/10.1007/s00787-013-0375-0.

    Article 
    PubMed 

    Google Scholar
     

  • 33.

    Lord C, Rutter M, DiLavore P, Risi S, Gotham K, Bishop S. Autism Diagnostic Observation Schedule-2nd edition (ADOS-2): Los Angeles. CA: Western Psychological Corporation; 2012.


    Google Scholar
     

  • 34.

    Le Couteur A, Lord C, Rutter M. The Autism Diagnostic Interview-Revised (ADI-R): Los Angeles, CA: Western Psychological Services; 2003.

  • 35.

    Garg S, Plasschaert E, Descheemaeker MJ, Huson S, Borghgraef M, Vogels A, et al. Autism spectrum disorder profile in neurofibromatosis type 1. J Autism Dev Disord. 2015;45(6):1649–57. https://doi.org/10.1007/s10803-014-2321-5.

    Article 
    PubMed 

    Google Scholar
     

  • 36.

    Garg S, Heuvelman H, Huson S, Tobin H, Green J. Sex bias in autism spectrum disorder in neurofibromatosis type 1. J Neurodev Disord. 2016;8(26):1–8. https://doi.org/10.1186/s11689-016-9159-4.

    Article 

    Google Scholar
     

  • 37.

    Geoffray MM, Falissard B, Green J, Kerr B, Evans DG, Huson S, et al. Autism spectrum disorder symptom profile across the RASopathies. Front Psychiatry. 2021;11: 585700. https://doi.org/10.3389/fpsyt.2020.585700.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 38.

    Aoki Y, Niihori T, Inoue S-i, Matsubara Y. Recent advances in RASopathies. J Hum Genet. 2016;61(1):33–9. https://doi.org/10.1038/jhg.2015.114.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 39.

    Rauen KA. The rasopathies. Annu Rev Genomics Hum Genet. 2013;14:355–69. https://doi.org/10.1146/annurev-genom-091212-153523.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 40.

    Hus V, Gotham K, Lord C. Standardizing ADOS domain scores: separating severity of social affect and restricted and repetitive behaviors. J Autism Dev Disord. 2014;44(10):2400–12. https://doi.org/10.1007/s10803-012-1719-1.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 41.

    Morotti H, Mastel S, Keller K, Barnard RA, Hall T, O’Roak BJ, et al. The association of neurofibromatosis and autism symptomatology is confounded by behavioral problems. medRxiv. 2019. https://doi.org/10.1101/2019.12.20.19015420

  • 42.

    Fombonne E, Morotti H, Mastel S, Keller K, Barnard RA, Hall T, et al. Autism questionnaire scores do not only rise because of autism. Dev Med Child Neurol. 2021;63(2):235–6. https://doi.org/10.1111/dmcn.14725.

    Article 
    PubMed 

    Google Scholar
     

  • 43.

    Morris SM, Acosta MT, Garg S, Green J, Legius E, North K, et al. Autism in neurofibromatosis type 1: misuse of covariance to dismiss autistic trait burden. Dev Med Child Neurol. 2021;63(2):233–4. https://doi.org/10.1111/dmcn.14653.

    Article 
    PubMed 

    Google Scholar
     

  • 44.

    Klein-Tasman BP. Are the autism symptoms in neurofibromatosis type 1 actually autism? Dev Med Child Neurol. 2021;63(2):132. https://doi.org/10.1111/dmcn.14597.

    Article 
    PubMed 

    Google Scholar
     

  • 45.

    Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry. 2008;47(8):921–9. https://doi.org/10.1097/CHI.0b013e318179964f.

    Article 
    PubMed 

    Google Scholar
     

  • 46.

    Aldridge FJ, Gibbs VM, Schmidhofer K, Williams M. Investigating the clinical usefulness of the Social Responsiveness Scale (SRS) in a tertiary level, autism spectrum disorder specific assessment clinic. J Autism Dev Disord. 2012;42(2):294–300. https://doi.org/10.1007/s10803-011-1242-9.

    Article 
    PubMed 

    Google Scholar
     

  • 47.

    Happe F, Ronald A, Plomin R. Time to give up on a single explanation for autism. Nat Neurosci. 2006;9(10):1218–20. https://doi.org/10.1038/nn1770.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 48.

    Pride NA, North KN. The cognitive profile of NF1 children: therapeutic implications. Neurofibromatosis type 1: Springer; 2012. p. 55–69.

  • 49.

    Wang DL, Smith KB, Esparza S, Leigh FA, Muzikansky A, Park ER, et al. Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome. Genet Med. 2012;14(12):977–82. https://doi.org/10.1038/gim.2012.85.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 50.

    Cholemkery H, Mojica L, Rohrmann S, Gensthaler A, Freitag CM. Can autism spectrum disorders and social anxiety disorders be differentiated by the Social Responsiveness Scale in children and adolescents? J Autism Dev Disord. 2014;44(5):1168–82. https://doi.org/10.1007/s10803-013-1979-4.

    Article 
    PubMed 

    Google Scholar
     

  • 51.

    Grzadzinski R, Dick C, Lord C, Bishop S. Parent-reported and clinician-observed autism spectrum disorder (ASD) symptoms in children with attention deficit/hyperactivity disorder (ADHD): implications for practice under DSM-5. Mol Autism. 2016;7(1):1–12. https://doi.org/10.1186/s13229-016-0072-1.

    Article 

    Google Scholar
     

  • 52.

    Haebich KM, Pride NA, Walsh KS, Chisholm A, Rouel M, Maier A, et al. Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study. BMJ Open. 2019;9(9): e030601. https://doi.org/10.1136/bmjopen-2019-030601.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 53.

    Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol. 1988;45(5):575–8.

  • 54.

    American Psychiatric Association. Diagnostic and statistical manual of mental disorders-Fourth edition-Text revision (DSM-IV-TR): American Psychiatric Pub; 2000.

  • 55.

    Gotham K, Pickles A, Lord C. Standardizing ADOS scores for a measure of severity in autism spectrum disorders. J Autism Dev Disord. 2009;39(5):693–705. https://doi.org/10.1007/s10803-008-0674-3.

    Article 
    PubMed 

    Google Scholar
     

  • 56.

    Bal VH, Lord C. Replication of standardized ADOS domain scores in the Simons Simplex Collection. Autism Res. 2015;8(5):583–92. https://doi.org/10.1002/aur.1474.

    Article 
    PubMed Central 

    Google Scholar
     

  • 57.

    de Bildt A, Oosterling IJ, van Lang ND, Sytema S, Minderaa RB, van Engeland H, et al. Standardized ADOS scores: measuring severity of autism spectrum disorders in a Dutch sample. J Autism Dev Disord. 2011;41(3):311–9. https://doi.org/10.1007/s10803-010-1057-0.

    Article 
    PubMed 

    Google Scholar
     

  • 58.

    Wechsler D. Wechsler Preschool and Primary Scale of Intelligence-4th edition (WPPSI-IV). San Antonio, Tx: Pearson; 2012.

  • 59.

    Wechsler D. Wechsler Intelligence Scale for Children-5th edition (WISC-V): Bloomington, MN: Pearson; 2014.

  • 60.

    Bornstein MH, Hahn C-S, Suwalsky JT, Haynes OM. Socioeconomic status, parenting, and child development: The Hollingshead Four-Factor Index of Social Status and The Socioeconomic Index of Occupations: Lawrence Erlbaum Associates Publishers; 2003.

  • 61.

    Constantino JN, Gruber CP. Social Responsiveness Scale, Second edition. Los Angeles: Western Psychological Services; 2012.

  • 62.

    Conners CK. Conners’ Rating Scales-Revised. New York: Multi-Health Systems Inc.; 1997.


    Google Scholar
     

  • 63.

    Conners CK. Conners. 3rd ed. Toronto: Multi-Health Systems Inc; 2009.


    Google Scholar
     

  • 64.

    Achenbach TM, Rescorla LA. Child Behavior Checklist for ages 1 1/2–5: ASEBA. University of Vermont; 2000.

  • 65.

    Achenbach TM, Rescorla LA. Manual for the ASEBA school-age forms and profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth, and Families; 2001.


    Google Scholar
     

  • 66.

    Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Neurofibromatosis type 1. Nat Rev Dis Primers. 2017;3:17004. https://doi.org/10.1038/nrdp.2017.4.

    Article 
    PubMed 

    Google Scholar
     

  • 67.

    Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed: Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.

  • 68.

    Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995;57(1):289–300. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x.

    Article 

    Google Scholar
     

  • 69.

    Hinkle DE, Wiersma W, Jurs SG. Applied statistics for the behavioral sciences: Houghton Mifflin College Division; 2003.

  • 70.

    Vivanti G, Volkmar FR. National guideline for the assessment and diagnosis of autism spectrum disorders in Australia. J Autism Dev Disord. 2020;50:2252–4. https://doi.org/10.1007/s10803-019-03937-x.

    Article 

    Google Scholar
     

  • 71.

    Randall M, Egberts KJ, Samtani A, Scholten RJ, Hooft L, Livingstone N, et al. Diagnostic tests for autism spectrum disorder (ASD) in preschool children. Cochrane Database Syst Rev. 2018;7:CD009044. https://doi.org/10.1002/14651858.CD009044.pub2

  • 72.

    Noll RB, Reiter-Purtill J, Moore BD, Schorry EK, Lovell AM, Vannatta K, et al. Social, emotional, and behavioral functioning of children with NF1. Am J Med Genet A. 2007;143A(19):2261–73. https://doi.org/10.1002/ajmg.a.31923.

    Article 
    PubMed 

    Google Scholar
     

  • 73.

    Lewis AK, Porter MA, Williams TA, Bzishvili S, North KN, Payne JM. Facial emotion recognition, face scan paths, and face perception in children with neurofibromatosis type 1. Neuropsychology. 2017;31(4):361–70. https://doi.org/10.1037/neu0000340.

    Article 
    PubMed 

    Google Scholar
     

  • 74.

    Lewis AK, Porter MA, Williams TA, Bzishvili S, North KN, Payne JM. Attention to faces in social context in children with neurofibromatosis type 1. Dev Med Child Neurol. 2019;61(2):174–80. https://doi.org/10.1111/dmcn.13928.

    Article 
    PubMed 

    Google Scholar
     

  • 75.

    Cuccaro ML, Shao Y, Grubber J, Slifer M, Wolpert CM, Donnelly SL, et al. Factor analysis of restricted and repetitive behaviors in autism using the Autism Diagnostic Interview-R. Child Psychiatry Hum Dev. 2003;34(1):3–17. https://doi.org/10.1023/A:1025321707947.

    Article 
    PubMed 

    Google Scholar
     

  • 76.

    Szatmari P, Georgiades S, Bryson S, Zwaigenbaum L, Roberts W, Mahoney W, et al. Investigating the structure of the restricted, repetitive behaviours and interests domain of autism. J Child Psychol Psychiatry. 2006;47(6):582–90. https://doi.org/10.1111/j.1469-7610.2005.01537.x.

    Article 
    PubMed 

    Google Scholar
     

  • 77.

    Bishop SL, Hus V, Duncan A, Huerta M, Gotham K, Pickles A, et al. Subcategories of restricted and repetitive behaviors in children with autism spectrum disorders. J Autism Dev Disord. 2013;43(6):1287–97. https://doi.org/10.1007/s10803-012-1671-0.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 78.

    Gotham K, Bishop SL, Hus V, Huerta M, Lund S, Buja A, et al. Exploring the relationship between anxiety and insistence on sameness in autism spectrum disorders. Autism Res. 2013;6(1):33–41. https://doi.org/10.1002/aur.1263.

    Article 
    PubMed 

    Google Scholar
     

  • 79.

    Bishop SL, Richler J, Lord C. Association between restricted and repetitive behaviors and nonverbal IQ in children with autism spectrum disorders. Child Neuropsychol. 2006;12(4–5):247–67. https://doi.org/10.1080/09297040600630288.

    Article 
    PubMed 

    Google Scholar
     

  • 80.

    Payne JM, Hyman SL, Shores EA, North KN. Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior. Child Neuropsychol. 2011;17(4):313–29. https://doi.org/10.1080/09297049.2010.542746.

    Article 
    PubMed 

    Google Scholar
     

  • 81.

    Walsh KS, del Castillo A, Kennedy T, Karim AI, Semerjian C. A review of psychological, social, and behavioral functions in the RASopathies. J Pediatr Neuropsychol. 2020;6(3):131–42. https://doi.org/10.1007/s40817-020-00088-1.

    Article 

    Google Scholar
     

  • 82.

    Boyd BA, McBee M, Holtzclaw T, Baranek GT, Bodfish JW. Relationships among repetitive behaviors, sensory features, and executive functions in high functioning autism. Res Autism Spectr Disord. 2009;3(4):959–66. https://doi.org/10.1016/j.rasd.2009.05.003.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 83.

    Baribeau DA, Vigod S, Pullenayegum E, Kerns CM, Mirenda P, Smith IM, et al. Co-occurring trajectories of anxiety and insistence on sameness behaviour in autism spectrum disorder. Br J Psychiatry. 2021;218(1):20–7. https://doi.org/10.1192/bjp.2020.127.

    Article 
    PubMed 

    Google Scholar
     

  • 84.

    Cholemkery H, Kitzerow J, Rohrmann S, Freitag CM. Validity of the social responsiveness scale to differentiate between autism spectrum disorders and disruptive behaviour disorders. Eur Child Adolesc Psychiatry. 2014;23(2):81–93. https://doi.org/10.1007/s00787-013-0427-5.

    Article 
    PubMed 

    Google Scholar
     

  • 85.

    Hus V, Bishop S, Gotham K, Huerta M, Lord C. Factors influencing scores on the social responsiveness scale. J Child Psychol Psychiatry. 2013;54(2):216–24. https://doi.org/10.1111/j.1469-7610.2012.02589.x.

    Article 
    PubMed 

    Google Scholar
     

  • 86.

    Mody M, Belliveau JW. Speech and language impairments in autism: insights from behavior and neuroimaging. N Am J Med Sci. 2013;5(3):157–61. https://doi.org/10.7156/v5i3p157.

    Article 

    Google Scholar
     

  • 87.

    Cochet H, Byrne RW. Communication in the second and third year of life: relationships between nonverbal social skills and language. Infant Behav Dev. 2016;44:189–98. https://doi.org/10.1016/j.infbeh.2016.07.003.

    Article 
    PubMed 

    Google Scholar
     

  • 88.

    Anderson DK, Liang JW, Lord C. Predicting young adult outcome among more and less cognitively able individuals with autism spectrum disorders. J Child Psychol Psychiatry. 2014;55(5):485–94. https://doi:https://doi.org/10.1111/jcpp.12178

  • 89.

    Evans DW, Leckman JF, Carter A, Reznick JS, Henshaw D, King RA, et al. Ritual, habit, and perfectionism: the prevalence and development of compulsive-like behavior in normal young children. Child Dev. 1997;68(1):58–68. https://doi.org/10.2307/1131925.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 90.

    Vivanti G, Prior M, Williams K, Dissanayake C. Predictors of outcomes in autism early intervention: why don’t we know more? Front Pediatr. 2014;2:58. https://doi.org/10.3389/fped.2014.00058.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 91.

    Howlin P, Magiati I, Charman T. Systematic review of early intensive behavioral interventions for children with autism. Am J Intellect Dev Disabil. 2009;114(1):23–41. https://doi.org/10.1352/2009.114:23-41.

    Article 
    PubMed 

    Google Scholar
     

  • 92.

    Fuentes J, Hervás A, Howlin P. ESCAP practice guidance for autism: a summary of evidence-based recommendations for diagnosis and treatment. Eur Child Adolesc Psychiatry. 2021;30(6):961–84. https://doi.org/10.1007/s00787-020-01587-4.

    Article 
    PubMed 

    Google Scholar
     

  • 93.

    Darling SJ, Goods M, Ryan NP, Chisholm AK, Haebich K, Payne JM. Behavioral intervention for social challenges in children and adolescents: a systematic review and meta-analysis. JAMA Pediatr. 2021;175(12):e213982. https://doi.org/10.1001/jamapediatrics.2021.3982.

  • 94.

    Zachor DA, Ben-Itzchak E. Variables affecting outcome of early intervention in autism spectrum disorder. J Pediatr Neurol. 2017;15(3):129–33. https://doi.org/10.1055/s-0037-1601444.

    Article 

    Google Scholar
     

  • 95.

    Havdahl KA, Bal VH, Huerta M, Pickles A, Øyen A-S, Stoltenberg C, et al. Multidimensional influences on autism symptom measures: implications for use in etiological research. J Am Acad Child Adolesc Psychiatry. 2016;55(12):1054–63. https://doi.org/10.1016/j.jaac.2016.09.490.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 96.

    Bettegowda C, Upadhayaya M, Evans DG, Kim A, Mathios D, Hanemann CO, et al. Genotype-phenotype correlations in neurofibromatosis and their potential clinical use. Neurology. 2021;97(7 Supplement 1):S91–8. https://doi.org/10.1212/WNL.0000000000012436.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 97.

    Grove J, Ripke S, Als TD, Mattheisen M, Walters RK, Won H, et al. Identification of common genetic risk variants for autism spectrum disorder. Nat Genet. 2019;51(3):431–44. https://doi.org/10.1038/s41588-019-0344-8.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 98.

    Jones RM, Risi S, Wexler D, Anderson D, Corsello C, Pickles A, et al. How interview questions are placed in time influences caregiver description of social communication symptoms on the ADI-R. J Child Psychol Psychiatry. 2015;56(5):577–85. https://doi.org/10.1111/jcpp.12325.

    Article 
    PubMed 

    Google Scholar
     

  • 99.

    Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism spectrum disorder. Lancet. 2018;392(10146):508–20. https://doi.org/10.1016/S0140-6736(18)31129-2.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 100.

    Zwaigenbaum L, Bauman ML, Choueiri R, Kasari C, Carter A, Granpeesheh D, et al. Early intervention for children with autism spectrum disorder under 3 years of age: recommendations for practice and research. Pediatrics. 2015;136(Supplement 1):S60–81. https://doi.org/10.1542/peds.2014-3667E.

    Article 
    PubMed 

    Google Scholar
     

  • Rights and permissions

    Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

    Disclaimer:

    This article is autogenerated using RSS feeds and has not been created or edited by OA JF.

    Click here for Source link (https://www.biomedcentral.com/)

    By admin